MHRA flags over 150 deaths linked to weight-loss drugs as adverse reports surge
TL;DR Summary
The MHRA reports more than 150 deaths linked to GLP-1 weight-loss drugs, based on around 150,000 adverse-reaction reports. Tirzepatide (Mounjaro) accounts for the majority of serious reports and near-100 fatalities; semaglutide (Wegovy) and liraglutide (Saxenda) also appear in the data. Regulators caution that reports do not prove causation and that benefits of GLP-1 medicines generally outweigh risks when used under medical supervision; manufacturers stress ongoing safety monitoring.
Topics:world#glp-1#health#medicines-and-healthcare-products-regulatory-agency#nhs#weight-loss#yellow-card-scheme
- More than 150 deaths reported after weight loss drug use independent.co.uk
- Hundreds of deaths suspected of being linked to weight-loss jabs reported to regulator news.sky.com
- More than 100 deaths after Mounjaro or Wegovy use reported The Times
- Nearly 200 deaths linked to weight-loss drugs Ozempic and Mounjaro in the UK The Times of India
- ‘Miracle’ weight loss drugs were never the answer. Now there’s proof The Telegraph
Reading Insights
Total Reads
0
Unique Readers
2
Time Saved
11 min
vs 12 min read
Condensed
97%
2,336 → 67 words
Want the full story? Read the original article
Read on independent.co.uk